Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Pharmaceuticals: Other
Sector Health Technology
Employees 21,600
CEO Mr. Joseph C. Papa
Address 2150 St. Elzéar Boulevard West , Laval, QC H7L 4A8
Phone 1.514.744.6792
Website www.bauschhealth.com

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Salix segment consists of sales in the U.S. of GI products. The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Bausch Health Cos., Inc. -17.01% 26.37%
Novo Nordisk A/S 6.80% 61.51%
Eli Lilly & Co. -5.09% 63.52%
Abbott Laboratories 2.74% 22.70%
Danaher Corp. -7.68% 40.24%

Statement Summary

as of 4:10 ET PM 12/03/2021
Total Assets (MRQ) 29.3 B
Total Liabilities (MRQ) 29.4 B
Shareholders’ Equity (MRQ) -135.0 M
Total Revenue (Annual) 2.1 B
Net Income (Annual) 188.0 M

Earnings And Estimates

as of 4:10 ET PM 12/03/2021

Current Qtr EPS Estimate 1.12
Current FY EPS Estimate 4.24
Long Term EPS Growth Estimate 7.57
Next Expected Earnings Date //

BHC vs S&P 500

as of 12/03/2021
Relative To
S&P 500
BHC
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:10 ET PM 12/03/2021
Fiscal Quarter Estimate Actual Surprise
09/2021 1.04 1.15 +10.10%
06/2021 0.95 0.94 -0.23%
03/2021 0.95 0.99 +3.59%
12/2020 1.12 1.33 +18.42%
09/2020 1.02 1.31 +28.56%
06/2020 0.66 0.45 -31.09%
03/2020 0.88 0.89 +1.09%
12/2019 1.15 1.05 -9.13%

Financial Strength

as of 4:10 ET PM 12/03/2021
Pre-Tax Margin 10.23
Net Margin 168.18
Operating Margin 19.75
Return On Equity -610.97
Return On Assets -3.85
Inventory Turnover (TTM) 3.37
Sales Growth (MRQ) -5.13

Ratios

as of 4:10 PM ET 12/03/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 0.00
Price/Cash Flow (TTM) 5.02
Book Value (MRQ) -0.57
Quick Ratio (MRQ) 0.78
Current Ratio (MRQ) 0.98
Total Debt/Equity (MRQ) 0.00

Short Interest

as of 10:36 AM ET 12/07/2021
% Short - 3.68%
% Remaining Float - 96.32%
Current Last Month
Short Interest Date 11/15/2021 10/29/2021
Short Interest Shares 12,809,865 14,582,615
Short Interest Ratio 3.8 10.1
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:10 ET PM 12/06/2021
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Consensus Estimate $1.12 $1.12
# of Estimates 9 3
High Estimate $1.23 $1.35
Low Estimate $0.98 $0.98
Year Ago EPS $-0.43 $-1.71
Year Over Year Growth Estimate -359.65% -165.71%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $4.24 $4.76
# of Estimates 10 11
High Estimate $4.37 $5.60
Low Estimate $4.11 $4.11
Year Ago EPS $3.97 $4.24
Year Over Year Growth Estimate 6.75% 12.38%
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $1.12 $1.12 $4.24 $4.76
# of Estimates 9 3 10 11
High Estimate $1.23 $1.35 $4.37 $5.60
Low Estimate $0.98 $0.98 $4.11 $4.11
Year Ago EPS $-0.43 $-1.71 $3.97 $4.24
Year Over Year Growth Estimate -359.65% -165.71% 6.75% 12.38%

Insider Information Summary

as of 11/30/2021
% Insiders - 3.01%
% Remaining Total Shares - 96.99%
Current 1 Month
Net Insider Transaction 216.88 K 128.97 K
Shares Bought 234.57 K 159.24 K
Shares Sold 17.68 K 30.27 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Jim Cramer Is Keeping an Eye on Constellation Brands

Constellation Brands Reportedly to Build $1.3B Brewery in Mexico

Constellation Brands, producer of Corona beer, in 2020 was forced to close a nearly completed $1.4 billion Mexican facility after local opposition arose.

NFL Lead

DraftKings And NFL Players Association Team Up For NFTs

Starting next year, you can use tokens with players’ likenesses for fantasy games.

Google to Strengthen Ad Policy Amid Controversy

Digital Ads (Led By Google and Facebook) to Dominate Ad Spending by 2026

The advertising market continued to expand much more quickly than forecasters earlier predicted in 2021.

Microsoft Nuance Lead

Microsoft-Nuance Deal Could Be Killed By European Regulators

EC's competition bureau is querying Nuance’s customers and competitors to get their take on the takeover.

Starbucks Coffee Shop Lead

Starbucks Stock Percolates on MKM Partners Upgrade to Buy

Starbucks shares rise as an MKM Partners analyst says he is 'taking a more constructive view of the company's long-term prospects.'

Cyber Security Stocks Surge

Mimecast Stock Rises on $5.8B Pact to Be Bought by PE Firm Permira

Mimecast shares jumped after the e-mail-security software maker agreed to be bought by PE firm Permira for $80 a share, or $5.8 billion, cash.

Wall Street Awaits Elon Musk's Biggest Decision on Tesla Ever

How Elon Musk Sold $1B of Tesla Stock, Yet Now Owns Even More

Tesla CEO Elon Musk has sold more than $1 billion of stock, yet now owns even more than he did when he started selling, a media report says.

Boeing Lead

Boeing Stock Jumps After $3.7 Billion 737 MAX Aircraft Sale to 777 Partners

Boeing said Miami-based 777 Partners boosted its 737 MAX order by adding another 30 planes at a list price of $3.7 billion

Omicron COVID-19 Lead

AutoZone Stock Up; Earnings Beat Amid Huge Used-Car Demand

Car-parts retailer AutoZone reported a profit beat amid widely reported huge demand for used cars.

Toyota Teams Up With Self-driving Start-up Momenta To Develop HD Mapping Tech In China

Toyota Plans to Build $1.3 Billion Battery Plant in North Carolina

Toyota says it is committed to using 100% renewable energy at the new North Carolina facility to produce batteries.